Abstract
Analysis of saliva samples from individuals aged ≥60 years who had a history of zoster (group 1), zoster and postherpetic neuralgia (PHN; group 2), or no history of zoster (group 3) revealed varicella zoster virus (VZV) DNA in saliva samples from 11 of 17 individuals in group 1, 10 of 15 individuals in group 2, and 2 of 17 individuals in group 3. The frequency of VZV DNA detection was significantly higher (P = .001) in saliva of subjects with a history of zoster, with or without PHN (21 [67%] of 32 subjects in groups 1 and 2), than in saliva of age-matched subjects with no zoster history (2 [12%] of 17 subjects in group 3). Thus, persistence of VZV DNA in saliva is the outcome of zoster, independent of PHN. Because VZV infection can produce neurological and ocular disease without zoster rash, future studies are needed to establish whether VZV DNA can be detected in the saliva of such patients. © The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
Cite
CITATION STYLE
Nagel, M. A., Choe, A., Cohrs, R. J., Traktinskiy, I., Sorensen, K., Mehta, S. K., … Gilden, D. (2011). Persistence of varicella zoster virus DNA in saliva after herpes zoster. Journal of Infectious Diseases, 204(6), 820–824. https://doi.org/10.1093/infdis/jir425
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.